This $3 million grant will support research on tobacco-related illnesses other than cancer, such as cardiovascular disease, stroke, chronic pulmonary disease, peripheral vascular disease, and infant mortality due to low birth weight.
This grant also will allow the University of Maryland School of Medicine to conduct research in three areas: clinical research, translational research, and health services research, which will look at the best methods of delivering health care to and increasing recruitment of diverse populations to clinical research, and policies and other barriers which impede the delivery of quality health care services.
